Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diclofenac + linseed oil + menthol + methyl salicylate (Zinnia Life Sciences)
- Development stage
- Unknown
- Lead developer
- Zinnia Life Sciences
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Zinidol (available as Zinidol Gel and Zinidol Liniment) is a topical fixed-dose combination analgesic and anti-inflammatory formulation developed by Zinnia Life Sciences. It contains diclofenac diethylamine (equivalent to diclofenac sodium), linseed oil, menthol, and methyl salicylate. Diclofenac acts as a non-steroidal anti-inflammatory drug (NSAID) by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby reducing prostaglandin synthesis to alleviate pain and swelling. Methyl salicylate and menthol act as counterirritants that stimulate transient receptor potential (TRP) channels (such as TRPM8, TRPA1, and TRPV1) to produce cooling and warming sensations, which distract from deeper musculoskeletal pain. Linseed oil serves as a penetration enhancer and provides mild anti-inflammatory effects. Zinidol is indicated for the localized relief of pain and inflammation associated with musculoskeletal disorders, including osteoarthritis, backaches, sprains, strains, and sports injuries.
- Brand names
- ZinidolZinidol GelZinidol Liniment
- Other names
- diclofenac + linseed oil + menthol + methyl salicylatediclofenac diethylamine + linseed oil + menthol + methyl salicylate
02
Targets
PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPA1 (Transient receptor potential cation channel subfamily A member 1)TRPM8 (Transient receptor potential cation channel subfamily M member 8)TRPV1 (Transient receptor potential cation channel subfamily V member 1)PGHS-1 (Prostaglandin G/H Synthase 1)
Beyond the preview
Go deeper on diclofenac + linseed oil + menthol + methyl salicylate (Zinnia Life Sciences).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diclofenac + linseed oil + menthol + methyl salicylate (Zinnia Life Sciences).